Search clinical trials for: bladder tumor
Total 35659 results
-
National Cancer Institute (NCI)CompletedNon-Hodgkin LymphomaUnited States
-
Federico II UniversityUniversity of GenovaCompleted
-
Hellenic Cooperative Oncology GroupUniversity of IoanninaCompletedBreast Cancer | Prostate Cancer | Non Small Cell Lung CancerGreece
-
Avera PharmaceuticalsTerminatedOveractive Bladder SyndromeNetherlands, United Kingdom
-
Atrium Medical CenterMaastricht UniversityUnknown
-
University Hospital TuebingenCompletedLung Cancer | Lung MetastasisGermany
-
Massachusetts General HospitalCompletedGrowth Hormone DeficiencyUnited States
-
Myrexis Inc.CompletedRefractory Solid TumorsUnited States
-
SanofiCompletedNeoplasms, Germ Cell and EmbryonalFrance
-
Millennium Pharmaceuticals, Inc.Completed
-
McGill University Health Centre/Research Institute...Terminated
-
Rabin Medical CenterUnknownCentral Nervous System Tumors | TumorsIsrael
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Non Small CellUnited States
-
National Taiwan University HospitalTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Tabriz UniversityUnknownNeurogenic Bladder
-
Tehran University of Medical Sciencesdepartment of radiation oncologyUnknownHead and Neck CancerIran, Islamic Republic of
-
APOGEPHA Arzneimittel GmbHCompletedOveractive Bladder | Urinary Incontinence | Children
-
SanofiCompletedHyperuricemiaKorea, Republic of
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Terminated
-
St. Justine's HospitalGraceway Pharmaceuticals, LLCCompletedHemangioma, CapillaryCanada
-
University of MilanCompletedHepatocellular Carcinoma | Colorectal Liver MetastasesItaly
-
Erimos PharmaceuticalsCompleted
-
NovartisProcter and GambleCompletedUrinary IncontinenceUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
NovartisProcter and GambleCompleted
-
Rigshospitalet, DenmarkDanish Heart Foundation; Copenhagen Hospital CorporationTerminatedSystemic Inflammatory Response Syndrome | Coronary ArteriosclerosisDenmark
-
Peking UniversityFudan University; Capital Medical UniversityUnknownStomach Neoplasms | Gastric CancerChina
-
Hebrew University of JerusalemAnchiano Therapeutics Israel Ltd.Completed
-
Aptose Biosciences Inc.Completed
-
Celtic Pharma Development ServicesNeurobiological TechnologiesWithdrawnBrain Tumor | Brain EdemaUnited States, Canada
-
University Hospital, GhentCompletedMicturition DisorderBelgium
-
Dana-Farber Cancer InstituteBoston Children's HospitalTerminated
-
University Hospital, GhentCompleted
-
National Institute of Arthritis and Musculoskeletal...FDA Office of Orphan Products DevelopmentCompleted
-
University Hospital, GhentCompletedVerrucae VulgaresBelgium
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Tumors | Subcutaneous Tumors | Lymph Node TumorsUnited States
-
AmgenCompletedGenital Neoplasms, Female | Anemia | Gynecological Malignancies
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedBreast CancerUnited States
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Epeius BiotechnologiesTerminatedPancreatic CancerUnited States
-
Jagiellonian UniversityCompletedGastric Cancer | Pancreatic CancerPoland
-
AstraZenecaCompletedHead and Neck CancerHong Kong, Singapore
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsCompleted
-
Unither PharmaceuticalsTerminatedOvarian NeoplasmsCanada, United States